338 related articles for article (PubMed ID: 12522132)
1. Phosphorylation of tyrosine 319 of the angiotensin II type 1 receptor mediates angiotensin II-induced trans-activation of the epidermal growth factor receptor.
Seta K; Sadoshima J
J Biol Chem; 2003 Mar; 278(11):9019-26. PubMed ID: 12522132
[TBL] [Abstract][Full Text] [Related]
2. An angiotensin II type 1 receptor mutant lacking epidermal growth factor receptor transactivation does not induce angiotensin II-mediated cardiac hypertrophy.
Zhai P; Galeotti J; Liu J; Holle E; Yu X; Wagner T; Sadoshima J
Circ Res; 2006 Sep; 99(5):528-36. PubMed ID: 16902180
[TBL] [Abstract][Full Text] [Related]
3. Regulation of angiotensin II-induced JAK2 tyrosine phosphorylation: roles of SHP-1 and SHP-2.
Marrero MB; Venema VJ; Ju H; Eaton DC; Venema RC
Am J Physiol; 1998 Nov; 275(5):C1216-23. PubMed ID: 9814969
[TBL] [Abstract][Full Text] [Related]
4. Angiotensin II type 2 receptor inhibits epidermal growth factor receptor transactivation by increasing association of SHP-1 tyrosine phosphatase.
Shibasaki Y; Matsubara H; Nozawa Y; Mori Y; Masaki H; Kosaki A; Tsutsumi Y; Uchiyama Y; Fujiyama S; Nose A; Iba O; Tateishi E; Hasegawa T; Horiuchi M; Nahmias C; Iwasaka T
Hypertension; 2001 Sep; 38(3):367-72. PubMed ID: 11566906
[TBL] [Abstract][Full Text] [Related]
5. Angiotensin AT(1) and AT(2) receptors differentially regulate angiopoietin-2 and vascular endothelial growth factor expression and angiogenesis by modulating heparin binding-epidermal growth factor (EGF)-mediated EGF receptor transactivation.
Fujiyama S; Matsubara H; Nozawa Y; Maruyama K; Mori Y; Tsutsumi Y; Masaki H; Uchiyama Y; Koyama Y; Nose A; Iba O; Tateishi E; Ogata N; Jyo N; Higashiyama S; Iwasaka T
Circ Res; 2001 Jan; 88(1):22-9. PubMed ID: 11139469
[TBL] [Abstract][Full Text] [Related]
6. Pivotal role of tyrosine phosphatase SHP-1 in AT2 receptor-mediated apoptosis in rat fetal vascular smooth muscle cell.
Cui T; Nakagami H; Iwai M; Takeda Y; Shiuchi T; Daviet L; Nahmias C; Horiuchi M
Cardiovasc Res; 2001 Mar; 49(4):863-71. PubMed ID: 11230986
[TBL] [Abstract][Full Text] [Related]
7. Differential pathways of angiotensin II-induced extracellularly regulated kinase 1/2 phosphorylation in specific cell types: role of heparin-binding epidermal growth factor.
Shah BH; Yesilkaya A; Olivares-Reyes JA; Chen HD; Hunyady L; Catt KJ
Mol Endocrinol; 2004 Aug; 18(8):2035-48. PubMed ID: 15143154
[TBL] [Abstract][Full Text] [Related]
8. Angiotensin II type 1 receptor-induced extracellular signal-regulated protein kinase activation is mediated by Ca2+/calmodulin-dependent transactivation of epidermal growth factor receptor.
Murasawa S; Mori Y; Nozawa Y; Gotoh N; Shibuya M; Masaki H; Maruyama K; Tsutsumi Y; Moriguchi Y; Shibazaki Y; Tanaka Y; Iwasaka T; Inada M; Matsubara H
Circ Res; 1998 Jun; 82(12):1338-48. PubMed ID: 9648731
[TBL] [Abstract][Full Text] [Related]
9. The N-terminal SH2 domain of the tyrosine phosphatase, SHP-2, is essential for Jak2-dependent signaling via the angiotensin II type AT1 receptor.
Godeny MD; Sayyah J; VonDerLinden D; Johns M; Ostrov DA; Caldwell-Busby J; Sayeski PP
Cell Signal; 2007 Mar; 19(3):600-9. PubMed ID: 17027227
[TBL] [Abstract][Full Text] [Related]
10. Regulation of calcium-sensitive tyrosine kinase Pyk2 by angiotensin II in endothelial cells. Roles of Yes tyrosine kinase and tyrosine phosphatase SHP-2.
Tang H; Zhao ZJ; Landon EJ; Inagami T
J Biol Chem; 2000 Mar; 275(12):8389-96. PubMed ID: 10722671
[TBL] [Abstract][Full Text] [Related]
11. Adenovirus-mediated overexpression and stimulation of the human angiotensin II type 2 receptor in porcine cardiac fibroblasts does not modulate proliferation, collagen I mRNA expression and ERK1/ERK2 activity, but inhibits protein tyrosine phosphatases.
Warnecke C; Kaup D; Marienfeld U; Poller W; Yankah C; Gräfe M; Fleck E; Regitz-Zagrosek V
J Mol Med (Berl); 2001 Sep; 79(9):510-21. PubMed ID: 11692164
[TBL] [Abstract][Full Text] [Related]
12. Effect of angiotensin II type 2 receptor on tyrosine kinase Pyk2 and c-Jun NH2-terminal kinase via SHP-1 tyrosine phosphatase activity: evidence from vascular-targeted transgenic mice of AT2 receptor.
Matsubara H; Shibasaki Y; Okigaki M; Mori Y; Masaki H; Kosaki A; Tsutsumi Y; Uchiyama Y; Fujiyama S; Nose A; Iba O; Tateishi E; Hasegawa T; Horiuchi M; Nahmias C; Iwasaka T
Biochem Biophys Res Commun; 2001 Apr; 282(5):1085-91. PubMed ID: 11302725
[TBL] [Abstract][Full Text] [Related]
13. Dependence on the motif YIPP for the physical association of Jak2 kinase with the intracellular carboxyl tail of the angiotensin II AT1 receptor.
Ali MS; Sayeski PP; Dirksen LB; Hayzer DJ; Marrero MB; Bernstein KE
J Biol Chem; 1997 Sep; 272(37):23382-8. PubMed ID: 9287353
[TBL] [Abstract][Full Text] [Related]
14. SHP-2 is a dual-specificity phosphatase involved in Stat1 dephosphorylation at both tyrosine and serine residues in nuclei.
Wu TR; Hong YK; Wang XD; Ling MY; Dragoi AM; Chung AS; Campbell AG; Han ZY; Feng GS; Chin YE
J Biol Chem; 2002 Dec; 277(49):47572-80. PubMed ID: 12270932
[TBL] [Abstract][Full Text] [Related]
15. Angiotensin II activates Stat5 through Jak2 kinase in cardiac myocytes.
McWhinney CD; Dostal D; Baker K
J Mol Cell Cardiol; 1998 Apr; 30(4):751-61. PubMed ID: 9602424
[TBL] [Abstract][Full Text] [Related]
16. Phosphorylation and recruitment of Syk by immunoreceptor tyrosine-based activation motif-based phosphorylation of tamalin.
Hirose M; Kitano J; Nakajima Y; Moriyoshi K; Yanagi S; Yamamura H; Muto T; Jingami H; Nakanishi S
J Biol Chem; 2004 Jul; 279(31):32308-15. PubMed ID: 15173175
[TBL] [Abstract][Full Text] [Related]
17. The protein-tyrosine phosphatase SHP-2 is required during angiotensin II-mediated activation of cyclin D1 promoter in CHO-AT1A cells.
Guillemot L; Levy A; Zhao ZJ; Bereziat G; Rothhut B
J Biol Chem; 2000 Aug; 275(34):26349-58. PubMed ID: 10843991
[TBL] [Abstract][Full Text] [Related]
18. Gbeta gamma -independent constitutive association of Galpha s with SHP-1 and angiotensin II receptor AT2 is essential in AT2-mediated ITIM-independent activation of SHP-1.
Feng YH; Sun Y; Douglas JG
Proc Natl Acad Sci U S A; 2002 Sep; 99(19):12049-54. PubMed ID: 12221292
[TBL] [Abstract][Full Text] [Related]
19. Involvement of PYK2 in angiotensin II signaling of vascular smooth muscle cells.
Eguchi S; Iwasaki H; Inagami T; Numaguchi K; Yamakawa T; Motley ED; Owada KM; Marumo F; Hirata Y
Hypertension; 1999 Jan; 33(1 Pt 2):201-6. PubMed ID: 9931105
[TBL] [Abstract][Full Text] [Related]
20. cAbl tyrosine kinase mediates reactive oxygen species- and caveolin-dependent AT1 receptor signaling in vascular smooth muscle: role in vascular hypertrophy.
Ushio-Fukai M; Zuo L; Ikeda S; Tojo T; Patrushev NA; Alexander RW
Circ Res; 2005 Oct; 97(8):829-36. PubMed ID: 16151024
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
